Product NDC: | 0024-4200 |
Proprietary Name: | Uroxatral |
Non Proprietary Name: | alfuzosin hydrochloride |
Active Ingredient(s): | 10 mg/1 & nbsp; alfuzosin hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0024-4200 |
Labeler Name: | sanofi-aventis U.S. LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021287 |
Marketing Category: | NDA |
Start Marketing Date: | 20090605 |
Package NDC: | 0024-4200-10 |
Package Description: | 1 BOTTLE in 1 CARTON (0024-4200-10) > 100 TABLET, EXTENDED RELEASE in 1 BOTTLE |
NDC Code | 0024-4200-10 |
Proprietary Name | Uroxatral |
Package Description | 1 BOTTLE in 1 CARTON (0024-4200-10) > 100 TABLET, EXTENDED RELEASE in 1 BOTTLE |
Product NDC | 0024-4200 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | alfuzosin hydrochloride |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20090605 |
Marketing Category Name | NDA |
Labeler Name | sanofi-aventis U.S. LLC |
Substance Name | ALFUZOSIN HYDROCHLORIDE |
Strength Number | 10 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |